Anti TNF-α in refractory Takayasu's arteritis: Cases series and review of the literature

Autoimmunity Reviews

Volumn 11, Issue 9, 2012, Pages 678-684

  Comarmond, Cloé ^a   Plaisier, Emmanuel ^a,c   Dahan, Karine ^a,c   Mirault, Tristan ^b,c   Emmerich, Joseph ^b,c   Amoura, Zahir ^a,c   Cacoub, Patrice ^a,c   Saadoun, David ^a,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Anti TNF ; Immunosuppressants; Takayasu's arteritis; Vasculitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADOLESCENT; ADULT; AORTA ARCH SYNDROME; BREAST CANCER; CHILD; CORTICOSTEROID THERAPY; DIARRHEA; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART FAILURE; HERPES ZOSTER; HISTOPLASMOSIS; HUMAN; HYPERTRANSAMINASEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NAUSEA; REFRACTORY TAKAYASU ARTERITIS; REMISSION; RESPIRATORY TRACT INFECTION; REVIEW; SCHOOL CHILD; SIDE EFFECT; SKIN INFECTION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUBERCULOSIS; VIRUS REACTIVATION;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TAKAYASU ARTERITIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84861756748     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.025     Document Type: Review

References (30)

1. Arend W.P., Michel B.A., Bloch D.A., Hunder G.G., Calabrese L.H., Edworthy S.M., et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990, 33:1129-1134.
2. Kerr G.S., Hallahan C.W., Giordano J., Leavitt R.Y., Fauci A.S., Rottem M., et al. Takayasu arteritis. Ann Intern Med 1994, 120:919-929.
3. Ishikawa K., Maetani S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors. Circulation 1994, 90:1855-1860.
4. Hoffman G.S. Treatment of resistant Takayasu's arteritis. Rheum Dis Clin North Am 1995, 21:73-80.
5. Mevorach D., Leibowitz G., Brezis M., Raz E. Induction of remission in a patient with Takayasu's arteritis by low dose pulses of methotrexate. Ann Rheum Dis 1992, 51:904-905.
6. Valsakumar A.K., Valappil U.C., Jorapur V., Garg N., Nityanand S., Sinha N. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. J Rheumatol 2003, 30:1793-1798.
7. Shelhamer J.H., Volkman D.J., Parrillo J.E., Lawley T.J., Johnston M.R., Fauci A.S. Takayasu's arteritis and its therapy. Ann Intern Med 1985, 103:121-126.
8. Hoffman G.S., Leavitt R.Y., Kerr G.S., Rottem M., Sneller M.C., Fauci A.S. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994, 37:578-582.
9. Inder S.J., Bobryshev Y.V., Cherian S.M., Lord R.S., Masuda K., Yutani C. Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease. Angiology 2000, 51:565-579.
10. Tripathy N.K., Chauhan S.K., Nityanand S. Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis. Clin Exp Immunol 2004, 138:369-374.
11. Tripathy N.K., Gupta P.C., Nityanand S. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu's arteritis. Clin Immunol 2006, 118:154-158. mars.
12. Wallis R.S., Ehlers S. Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum 2005, 34:34-38.
13. Hoffman G.S., Merkel P.A., Brasington R.D., Lenschow D.J., Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004, 50:2296-2304.
14. Molloy E.S., Langford C.A., Clark T.M., Gota C.E., Hoffman G.S. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008, 67:1567-1569.
15. Karageorgaki Z.T., Mavragani C.P., Papathanasiou M.A., Skopouli F.N. Infliximab in Takayasu arteritis: a safe alternative?. Clin Rheumatol 2007, 26:984-987.
16. Tanaka F., Kawakami A., Iwanaga N., Tamai M., Izumi Y., Aratake K., et al. Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate. Intern Med 2006, 45:313-316.
17. Calderón R., Estrada S., Ramírez de la Piscina P., Salvador M., Zabaleta S., Enciso C., et al. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis. Rev Esp Enferm Dig 2010, 102:145-146.
18. Buonuomo P.S., Bracaglia C., Campana A., Insalaco A., Pardeo M., Cortis E., et al. Infliximab therapy in pediatric Takayasu's arteritis: report of two cases. Rheumatol Int 2011, 31:93-95.
19. Jolly M., Curran J.J. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis. J Clin Rheumatol 2005, 11:213-215.
20. Maffei S., Di Renzo M., Santoro S., Puccetti L., Pasqui A.L. Refractory Takayasu arteritis successfully treated with infliximab. Eur Rev Med Pharmacol Sci 2009, 13:63-65.
21. Tatò F., Rieger J., Hoffmann U. Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab. Int Angiol 2005, 24:304-307.
22. Gecse K., Ruzsa Z., Nagy F., Wittmann T., Molnár T. Successful infliximab treatment in a patient with Takayasu arteritis associated with ulcerative colitis or migration does not override genetics. Inflamm Bowel Dis 2011, 17:E69-E70.
23. Nunes G., Neves F.S., Melo F.M., de Castro G.R.W., Zimmermann A.F., Pereira I.A. Takayasu arteritis: anti-TNF therapy in a Brazilian setting. Rev Bras Reumatol 2010, 50:291-298.
24. Katoh N., Kubota M., Shimojima Y., Ishii W., Matsuda M., Akamatsu T., et al. Takayasu's arteritis in a patient with Crohn's disease: an unexpected association during infliximab therapy. Intern Med 2010, 49:179-182.
25. Osman M., Aaron S., Noga M., Yacyshyn E. Takayasu's arteritis progression on anti-TNF biologics: a case series. Clin Rheumatol 2011, 30:703-706.
26. Filocamo G., Buoncompagni A., Viola S., Loy A., Malattia C., Ravelli A., et al. Treatment of Takayasu's arteritis with tumor necrosis factor antagonists. J Pediatr 2008, 153:432-434.
27. Della Rossa A., Tavoni A., Merlini G., Baldini C., Sebastiani M., Lombardi M., et al. Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?. Rheumatology (Oxford) 2005, 44:1074-1075.
28. Kaneko U., Kishi T., Kikuchi M., Hara R., Shinoki T., Miyamae T., et al. Infliximab therapy for three adolescent patients with refractory Takayasu's arteritis. Nihon Rinsho Meneki Gakkai Kaishi 2010, 33:317-323.
29. Mekinian A, Neel A, Sibilia J, Cohen P, Connault J, Lambert M, Federici L, Berthier S, Fiessinger JN, Bertrand G, Marie I, Guillevin L, Hamidou M, Fain O. Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicenter study. Rheumatology (Oxford) 2011; in press http://www.em-consulte.com/article/292708.
30. Vista E.G.S. Santos Estrella PV, Lichauco JJT. Flourine-18 flourodeoxyglucose positron emission tomography as a non-invasive test of disease activity in Takayasu's arteritis - A report of four cases. Autoimmun Rev 2010, 9:503-506.